Robot-assisted para-aortic lymph node dissection for uterine cancer

Safety and efficacy of robot-assisted para-aortic lymph node dissection in patients with uterine cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1042210047

Enrollment

Registered

2021-08-04

Start date

2021-08-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cancer uterine cancer, minimally invasive surgery

Interventions

Robot-assisted para-aortic lymph node dissection

D019060

minimal invasive surgery

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with uterine corpus cancer stage Ia, Ib, II, no lymph node metastasis

Exclusion criteria

Exclusion criteria: Patients with cerebral aneurysm and glaucoma

Design outcomes

Primary

Measure	Time frame
blood loss	—

Secondary

Measure	Time frame
intraoperative and postoperative complications, operative time, number of resected lymph nodes, postoperative QOL, recurrence rate	—

Contacts

Public ContactMichiko Kaneda

Mie university hospital

michi_k_1019@yahoo.co.jp+81-59-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026